Application note: Multiplexed automated imaging assay for cardiotoxic compounds using the ImageXpress Pico system
There is an increasing need to expand the variety and complexity of cell-based assays for biologic research and drug discovery.
Stem cell-derived cells and tissues have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. In this study, Molecular Devices scientists used human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to develop functional and morphological readouts for testing effects of different compounds in a multi-parametric assay format, using the ImageXpress Pico Automated Cell Imaging System.
Related content from this organisation
- Episode 11 – CRISPR with Dr Jakob Haaber, SNIPR Biome & Dr Richard Fox, Infinome Biosciences
- How 3D biology is shaping the future of drug discovery
- Molecular Devices launches automated workcells for ELISA workflows
- Episode 8 – 3D imaging with Hilary Sherman, Corning Life Sciences & Dr Oksana Sirenko, Molecular Devices
- Under the microscope: Unveiling a next-generation imaging system with deep learning technology